Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 19, 2009
Sat, October 17, 2009
Fri, October 16, 2009 STC, RES, NBIX, SNTS, ZIPR, ABTL Expected To Be Lower Leading Up To Next Earnings Releases
October 19, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and October/November earnings reports. Stewart Information Services (NYSE: STC), RPC Inc. (NYSE: RES), Neurocrine Biosciences (NASDAQ: NBIX), Santaurus (NASDAQ: SNTS), zipRealty (NASDAQ: ZIPR) and Autobytel (NASDAQ: ABTL) are all expected to be lower leading up to their next earnings release. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act before its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower leading up to their next earnings release:
Symbol Company # of Reports Quarter Release Date
STC Stewart Information 6 quarters Q3 10/29/2009
RES RPC Inc. 12 quarters Q3 10/28/2009
NBIX Neurocrine Biosciences 12 quarters Q3 10/27/2009
SNTS Santarus Inc. 12 quarters Q3 11/2/2009
ZIPR zipRealty Inc. 12 quarters Q3 11/3/2009
ABTL Autobytel Inc 12 quarters Q3 10/22/2009
Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
Stewart Information Services Corporation (NYSE: STC), through its subsidiaries, provides insurance and related information services required for settlement by the real estate and mortgage industries. The company operates in two segments, Title Insurance-Related Services and Real Estate Information (REI). The Title Insurance-Related Services segment provides services, such as searching for and examining documents, including deeds, mortgages, wills, divorce decrees, court judgments, paving assessments, and tax records, as well as offers title insurance for residential and commercial properties, undeveloped acreage, farms, ranches, and water rights. The REI segment provides electronic delivery of data, products, and services related to real estate, as well as origination and post-closing services, such as title and settlement services to residential mortgage lenders. Its products include basic vesting and legal description, mortgage modification services, conforming loan submissions, alternative products, and vendor management services. This segment also provides credit reporting services through credit bureaus, appraisal services and automated property valuations, and initial loan disclosures. In addition, it offers products and services, such as Internal Revenue Code Section 1031 tax-deferred property exchanges; real estate database conversion, construction, maintenance, and access; automation for government recording and registration; and pre-employment screening and background investigation services. The company has operations in the United States, Canada, the United Kingdom, Central Europe, Mexico, Central America, and Australia. It serves mortgage lenders and servicers, mortgage brokers, home buyers and sellers, government entities, commercial and residential real estate agents, land developers, builders, and title insurance agencies, as well as accountants, attorneys, and investors. The company was founded in 1893 and is based in Houston, Texas.
RPC, Inc. (NYSE: RES), an oil and gas services company, provides various oilfield services and equipment to the oil and gas companies. It operates in two segments, Technical Services and Support Services. The Technical Services segment offers pressure pumping, coiled tubing, snubbing, nitrogen pumping, well control consulting and firefighting, wireline, and fluid pumping services. This segment also provides downhole motors, fishing tools, and other specialized downhole tools. The Support Services segment offers equipment and services, including drill pipe and related tools; pipe handling, inspection, and storage services; and oilfield training services. This segment also involves in the rental of diverters, drill pipes, drill collars, handling tools, and hoses that are used for onshore and offshore oil and gas well drilling, completion, and workover activities. It serves companies that engage in the exploration, production, and development of oil and gas properties in the United States, including the Gulf of Mexico, mid-continent, southwest, and Rocky Mountain regions, as well as in Africa, Canada, China, eastern Europe, Latin America, and the Middle East. The company was founded in 1984 and is headquartered in Atlanta, Georgia.
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company develops drugs for endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine related diseases and disorders. Its products in clinical development comprise Elagolix, a Phase II product for Endometriosis; CRF1 Antagonist, a phase II product for mood disorders; CRF2 Peptide Agonist, a phase II drug for Cardiovascular related diseases; CRF1 Antagonist, a Phase I product for treating Mood Disorders and Irritable Bowel Syndrome; and Elagolix, a Phase I product for treating Benign Prostatic Hyperplasia and Uterine Fibroids. The companya�s research programs include Vesicular Monoamine Transporter 2 Inhibitor for movement disorders and schizophrenia; Glucose Dependent Insulin Secretagogues for type II diabetes; Antiepileptic drugs for epilepsy and bipolar disorder; and GnRH Antagonists for hormone dependent diseases and oncology. It has strategic alliances with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; and Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize indiplon in Japan. Neurocrine Biosciences, Inc. was founded in 1992 and is based in San Diego, California.
Santarus, Inc. (NASDAQ: SNTS), a specialty pharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that treat upper gastrointestinal diseases and disorders. Its products include Zegerid capsules and powder for oral suspension, which are proprietary immediate-release formulations that combine antacids and omeprazole (a proton pump inhibitor) to treat upper gastrointestinal diseases and disorders, including gastroesophageal reflux disease (GERD); and Glumetza for the treatment of type 2 diabetes. The company is also developing a Zegerid tablet formulation, Budesonide MMX for the treatment of mild or moderate active ulcerative colitis, and Rifamycin SV MMX for the treatment of travelera�s diarrhea. It has strategic alliances with Schering-Plough to develop, manufacture, and sell Zegerid brand OTC products in the lower dosage strength of 20 mg of omeprazole in the United States and Canada; GlaxoSmithKline to develop, manufacture, and commercialize prescription and OTC products in approximately 100 countries, including in Africa, Asia, the Middle-East, and Central and South America; and Cosmo Technologies, Ltd, which grants Santarus exclusive rights to develop and commercialize Budesonide MMX and Rifamycin SV MMX for the United States market. The company sells its products to wholesale distributors in the pharmaceutical industry. Santarus was founded in 1996 and is based in San Diego, California.
ZipRealty, Inc. (NASDAQ: ZIPR), a residential real estate brokerage company, together with its subsidiaries, provides brokerage services to home buyers and sellers in the United States. The company, through its Website ziprealty.com, provides multiple listing services (MLSs) access for home listings data, including pictures from the local MLSs; schedule visits of properties; and ZipNotify, a consumer Website tool to receive an automatic email notification each time a property that meets consumersa� desired search criteria is made available on the local MLSs. Its Website also offers neighborhood data and related information, such as new home listings, population, comparable home sales, average income, education level, occupation mix, cost of living, crime statistics, weather, school district information, maps, and driving directions; online images and virtual tours; and home offers by clients. The company also operates ZipAgent Platform (ZAP), a Web-based system to automatically match users with local ZipAgents to market and assist in showing properties to buyers, and listing and marketing properties on behalf of sellers, as well as assisting in negotiating, advisory, transaction processing, and closing activities. Its ZAP technology also systematically integrates and records consumer behavior, such as logon frequency and times, specific homes viewed and printed, searches made by clients, requested visits to view a home, and online offers; and ZipAgent activities, such as frequency and length of ZipAgent logins, and capturing and storing email communications organized by client. The company offers its services through employee-agents in Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, North Carolina, Pennsylvania, South Carolina, Texas, Utah, Virginia, Washington, and the District of Columbia. ZipRealty, Inc. was founded in 1999 and is headquartered in Emeryville, California.
Autobytel Inc. (NASDAQ: ABTL) operates as an automotive marketing services company that assists automotive dealers and manufacturers sell automobiles in the United States. The company provides lead and advertising programs for automotive manufacturers and other automotive advertisers through its marketing network, which includes its AutoReach advertising network and co-branded Web sites. It also owns and operates consumer-facing automotive Web sites comprising Autobytel.com, Autoweb.com, AutoSite.com, Car.com, CarSmart.com, CarTV.com, and MyRide.com that provide consumers with up-to-date vehicle specifications, vehicle safety features, and vehicle pricing information to make a vehicle lease or purchase decision. Autobytel was formerly known as autobytel.com inc. The company was founded in 1995 and is headquartered in Irvine, California.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com
Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
